1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Animal-derived Immune Globulin Products Revenue
1.4 Market Analysis by Type
1.4.1 Global Animal-derived Immune Globulin Products Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 IVIg Liquid
1.4.3 IVIg Powder
1.5 Market by Application
1.5.1 Global Animal-derived Immune Globulin Products Market Share by Application: 2021-2026
1.5.2 Immunodeficiency
1.5.3 Autoimmune Disease
1.5.4 Acute Infection
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Animal-derived Immune Globulin Products Market
1.8.1 Global Animal-derived Immune Globulin Products Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Animal-derived Immune Globulin Products Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Animal-derived Immune Globulin Products Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Animal-derived Immune Globulin Products Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Animal-derived Immune Globulin Products Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Animal-derived Immune Globulin Products Sales Volume Market Share by Region (2015-2020)
3.2 Global Animal-derived Immune Globulin Products Sales Revenue Market Share by Region (2015-2020)
3.3 North America Animal-derived Immune Globulin Products Sales Volume
3.3.1 North America Animal-derived Immune Globulin Products Sales Volume Growth Rate (2015-2020)
3.3.2 North America Animal-derived Immune Globulin Products Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Animal-derived Immune Globulin Products Sales Volume
3.4.1 East Asia Animal-derived Immune Globulin Products Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Animal-derived Immune Globulin Products Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Animal-derived Immune Globulin Products Sales Volume (2015-2020)
3.5.1 Europe Animal-derived Immune Globulin Products Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Animal-derived Immune Globulin Products Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Animal-derived Immune Globulin Products Sales Volume (2015-2020)
3.6.1 South Asia Animal-derived Immune Globulin Products Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Animal-derived Immune Globulin Products Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Animal-derived Immune Globulin Products Sales Volume (2015-2020)
3.7.1 Southeast Asia Animal-derived Immune Globulin Products Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Animal-derived Immune Globulin Products Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Animal-derived Immune Globulin Products Sales Volume (2015-2020)
3.8.1 Middle East Animal-derived Immune Globulin Products Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Animal-derived Immune Globulin Products Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Animal-derived Immune Globulin Products Sales Volume (2015-2020)
3.9.1 Africa Animal-derived Immune Globulin Products Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Animal-derived Immune Globulin Products Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Animal-derived Immune Globulin Products Sales Volume (2015-2020)
3.10.1 Oceania Animal-derived Immune Globulin Products Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Animal-derived Immune Globulin Products Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Animal-derived Immune Globulin Products Sales Volume (2015-2020)
3.11.1 South America Animal-derived Immune Globulin Products Sales Volume Growth Rate (2015-2020)
3.11.2 South America Animal-derived Immune Globulin Products Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Animal-derived Immune Globulin Products Sales Volume (2015-2020)
3.12.1 Rest of the World Animal-derived Immune Globulin Products Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Animal-derived Immune Globulin Products Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Animal-derived Immune Globulin Products Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Animal-derived Immune Globulin Products Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Animal-derived Immune Globulin Products Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Animal-derived Immune Globulin Products Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Animal-derived Immune Globulin Products Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Animal-derived Immune Globulin Products Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Animal-derived Immune Globulin Products Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Animal-derived Immune Globulin Products Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Animal-derived Immune Globulin Products Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Animal-derived Immune Globulin Products Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Animal-derived Immune Globulin Products Sales Volume Market Share by Type (2015-2020)
14.2 Global Animal-derived Immune Globulin Products Sales Revenue Market Share by Type (2015-2020)
14.3 Global Animal-derived Immune Globulin Products Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Animal-derived Immune Globulin Products Consumption Volume by Application (2015-2020)
15.2 Global Animal-derived Immune Globulin Products Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Animal-derived Immune Globulin Products Business
16.1 Pfizer
16.1.1 Pfizer Company Profile
16.1.2 Pfizer Animal-derived Immune Globulin Products Product Specification
16.1.3 Pfizer Animal-derived Immune Globulin Products Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Merck & Co
16.2.1 Merck & Co Company Profile
16.2.2 Merck & Co Animal-derived Immune Globulin Products Product Specification
16.2.3 Merck & Co Animal-derived Immune Globulin Products Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Rare Disease Therapeutics
16.3.1 Rare Disease Therapeutics Company Profile
16.3.2 Rare Disease Therapeutics Animal-derived Immune Globulin Products Product Specification
16.3.3 Rare Disease Therapeutics Animal-derived Immune Globulin Products Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Genzyme Corporation
16.4.1 Genzyme Corporation Company Profile
16.4.2 Genzyme Corporation Animal-derived Immune Globulin Products Product Specification
16.4.3 Genzyme Corporation Animal-derived Immune Globulin Products Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Instituto Bioclon
16.5.1 Instituto Bioclon Company Profile
16.5.2 Instituto Bioclon Animal-derived Immune Globulin Products Product Specification
16.5.3 Instituto Bioclon Animal-derived Immune Globulin Products Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Protherics
16.6.1 Protherics Company Profile
16.6.2 Protherics Animal-derived Immune Globulin Products Product Specification
16.6.3 Protherics Animal-derived Immune Globulin Products Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Sanofi
16.7.1 Sanofi Company Profile
16.7.2 Sanofi Animal-derived Immune Globulin Products Product Specification
16.7.3 Sanofi Animal-derived Immune Globulin Products Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Animal-derived Immune Globulin Products Manufacturing Cost Analysis
17.1 Animal-derived Immune Globulin Products Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Animal-derived Immune Globulin Products
17.4 Animal-derived Immune Globulin Products Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Animal-derived Immune Globulin Products Distributors List
18.3 Animal-derived Immune Globulin Products Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Animal-derived Immune Globulin Products (2021-2026)
20.2 Global Forecasted Revenue of Animal-derived Immune Globulin Products (2021-2026)
20.3 Global Forecasted Price of Animal-derived Immune Globulin Products (2015-2026)
20.4 Global Forecasted Production of Animal-derived Immune Globulin Products by Region (2021-2026)
20.4.1 North America Animal-derived Immune Globulin Products Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Animal-derived Immune Globulin Products Production, Revenue Forecast (2021-2026)
20.4.3 Europe Animal-derived Immune Globulin Products Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Animal-derived Immune Globulin Products Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Animal-derived Immune Globulin Products Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Animal-derived Immune Globulin Products Production, Revenue Forecast (2021-2026)
20.4.7 Africa Animal-derived Immune Globulin Products Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Animal-derived Immune Globulin Products Production, Revenue Forecast (2021-2026)
20.4.9 South America Animal-derived Immune Globulin Products Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Animal-derived Immune Globulin Products Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Animal-derived Immune Globulin Products by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Animal-derived Immune Globulin Products by Country
21.2 East Asia Market Forecasted Consumption of Animal-derived Immune Globulin Products by Country
21.3 Europe Market Forecasted Consumption of Animal-derived Immune Globulin Products by Countriy
21.4 South Asia Forecasted Consumption of Animal-derived Immune Globulin Products by Country
21.5 Southeast Asia Forecasted Consumption of Animal-derived Immune Globulin Products by Country
21.6 Middle East Forecasted Consumption of Animal-derived Immune Globulin Products by Country
21.7 Africa Forecasted Consumption of Animal-derived Immune Globulin Products by Country
21.8 Oceania Forecasted Consumption of Animal-derived Immune Globulin Products by Country
21.9 South America Forecasted Consumption of Animal-derived Immune Globulin Products by Country
21.10 Rest of the world Forecasted Consumption of Animal-derived Immune Globulin Products by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer